Virtu Financial LLC Myovant Sciences Ltd. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$7.78 - $14.69 $82,927 - $156,580	-10,659 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$11.38 - $16.4 $85,213 - $122,803	-7,488 Reduced 41.26%	10,659 $142,000
Q4 2021 Feb 17, 2022	BUY	$14.31 - $23.87 $28,319 - $47,238	1,979 Added 12.24%	18,147 $283,000
Q3 2021 Nov 12, 2021	SELL	$18.94 - $26.99 $61,308 - $87,366	-3,237 Reduced 16.68%	16,168 $363,000
Q2 2021 Sep 17, 2021	BUY	$17.07 - $24.56 $40,285 - $57,961	2,360 Added 13.85%	19,405 $442,000
Q1 2021 May 19, 2021	BUY	$20.46 - $25.18 $348,740 - $429,193	17,045 New	17,045 $351,000
Q3 2020 Dec 11, 2020	SELL	$14.05 - $22.6 $411,777 - $662,360	-29,308 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.34 - $20.84 $215,120 - $610,778	29,308 New	29,308 $604,000
Q3 2019 Nov 20, 2019	SELL	$5.19 - $9.46 $65,103 - $118,666	-12,544 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$8.69 - $25.0 $109,007 - $313,600	12,544 New	12,544 $114,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.